Compare KOSS & NEPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KOSS | NEPH |
|---|---|---|
| Founded | 1953 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Consumer Electronics/Appliances | Medical/Dental Instruments |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 32.8M | 39.0M |
| IPO Year | 1994 | 2004 |
| Metric | KOSS | NEPH |
|---|---|---|
| Price | $3.16 | $3.23 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $6.25 |
| AVG Volume (30 Days) | 21.8K | ★ 54.8K |
| Earning Date | 10-29-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 55.56 | ★ 1000.00 |
| EPS | N/A | ★ 0.12 |
| Revenue | $13,020,773.00 | ★ $18,789,000.00 |
| Revenue This Year | N/A | $17.81 |
| Revenue Next Year | N/A | $15.90 |
| P/E Ratio | ★ N/A | $27.33 |
| Revenue Growth | 3.14 | ★ 32.67 |
| 52 Week Low | $3.18 | $2.66 |
| 52 Week High | $5.10 | $6.42 |
| Indicator | KOSS | NEPH |
|---|---|---|
| Relative Strength Index (RSI) | 27.89 | 36.24 |
| Support Level | N/A | $3.15 |
| Resistance Level | $4.14 | $3.18 |
| Average True Range (ATR) | 0.18 | 0.23 |
| MACD | -0.05 | -0.02 |
| Stochastic Oscillator | 4.20 | 12.41 |
Koss Corp is engaged in the design, manufacture, and sale of stereo headphones and related accessory products. It operates in the audio/video industry segment of the home entertainment industry. The company markets a line of headphones, wireless Bluetooth headphones, wireless Bluetooth speakers, computer headsets, telecommunications headsets, and active noise-canceling headphones. The majority of the firm's revenue is derived from sales of stereo headphones. The Company also sells products to distributors for resale to school systems, and directly to other manufacturers for inclusion with their own products.
Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease. The company generates almost all of revenue from product sales and a small amount from royalty revenue and other revenues.